Financial News Feed

Weaker Buy Today ACRX ranks #374 as BUY CANDIDATE. Stronger Buy
Today ACRX ranks #374 as BUY CANDIDATE.

ACRX stock AcelRx Pharmaceuticals

ACRX stock
AcelRx Pharmaceuticals

Analysts expect AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) to post $1.05 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for A...

Read more

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)’s share price traded up 7.6% during mid-day trading on Tuesday . The stock traded as high as $3.47 and last traded at $3.41. 3,005,695 shares changed hands d...

Read more

AcelRx Pharmaceuticals Inc. (ACRX) had a good day on the market for Tuesday March 19 as shares jumped 7.57% to close at $3.41. About 2.97 million shares traded hands on 8,394 trades for the day,...

Read more

Keybank National Association decreased Thermo Fisher Scientific Inc (TMO) stake by 1.3% reported in 2018Q4 SEC filing. Keybank National Association sold 7,533 Sentiment for Acelrx Pharmaceuticals Inc ...

Read more

The stock of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is a huge mover today! The stock increased 5.05% or $0.16 during the last trading session, reaching TERRA TECH CORP (OTCMKTS:TRTC) had an increa...

Read more

Figuring out when to exit a certain position can be just as important as deciding which stocks to buy in the first place. Many investors will end up holding onto a loser for far too long. The emotiona...

Read more

Zacks Investment Research downgraded shares of AcelRx Pharmaceuticals (NASDAQ:ACRX) from a buy rating to a hold rating in a report issued on Monday. According to Zacks, “AcelRx Pharmaceuticals, Inc....

Read more

Analysts predict that AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) will post earnings per share (EPS) of ($0.24) for the current quarter, Zacks Investment Research reports. Three analysts have provided es...

Read more

Orthofix Medical Inc. (NASDAQ:OFIX) and AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) compete against each other in the Medical Appliances & Equipment sector. We will contrast them and contrast their inst...

Read more

During Q4 2018 the big money sentiment decreased to 1.46. That's change of 0.25, from 2018Q3's 1.71. 16 investors sold all, 8 reduced holdings as AcelRx...

Read more

Sentiment for Acelrx Pharmaceuticals Inc (NASDAQ:ACRX) Acelrx Pharmaceuticals Inc (NASDAQ:ACRX) institutional sentiment decreased to 1.46 in 2018 Q4. Its down -0.25, from 1.71 in 2018Q3. The ratio tur...

Read more

Checking in on the signals for Acelrx Pharmaceutica (ACRX), we have recently recorded the Chaikin Oscillator above zero. Traders may be watching for possible bullish momentum on the stock. Investing i...

Read more

We are contrasting ReShape Lifesciences Inc. (OTCMKTS:RSLS) and AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) on their analyst recommendations, profitability, risk, dividends, earnings and valuation, inst...

Read more

Looking at stock market performance over the last few months, new investors may be worried that they might have missed out on some fantastic opportunities. With so much information and data available,...

Read more

AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) is a company in the Medical Appliances & Equipment industry and that’s how we contrast it to its competitors. The comparing will be based on the profitabili...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank